Drug Type Small molecule drug |
Synonyms Tenofection |
Target |
Mechanism RT inhibitors(Reverse transcriptase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date KR (11 Aug 2017), |
Regulation- |
Molecular FormulaC19H30N5O10P |
InChIKeyJFVZFKDSXNQEJW-CQSZACIVSA-N |
CAS Registry201341-05-1 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Hepatitis B | KR | 11 Aug 2017 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hepatitis B, Chronic | Phase 2 | CN | ENYO Pharma SAStartup | 12 May 2020 |
Hepatitis B, Chronic | Phase 2 | AU | ENYO Pharma SAStartup | 12 May 2020 |
Hepatitis B, Chronic | Phase 2 | PL | ENYO Pharma SAStartup | 12 May 2020 |
Hepatitis B, Chronic | Phase 2 | KR | ENYO Pharma SAStartup | 12 May 2020 |